Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shane C Wright

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Molecular Metabolism|May 25, 2024
The novel adrenergic agonist ATR-127 targets skeletal muscle and brown adipose tissue to tackle diabesity and steatohepatitisEmanuela Talamonti, Jelena Davegardh, Anastasia Kalinovich, et al.
Nature Metabolism|June 13, 2024
Characterization of genetic variants of GIPR reveals a contribution of β-arrestin to metabolic phenotypesHüsün S Kizilkaya, Kimmie V Sørensen, Jakob S Madsen, et al.
Cell|June 24, 2025
GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesityAikaterini Motso, Benjamin Pelcman, Anastasia Kalinovich, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Molecular Metabolism|May 25, 2024
The novel adrenergic agonist ATR-127 targets skeletal muscle and brown adipose tissue to tackle diabesity and steatohepatitisEmanuela Talamonti, Jelena Davegardh, Anastasia Kalinovich, et al.
Nature Metabolism|June 13, 2024
Characterization of genetic variants of GIPR reveals a contribution of β-arrestin to metabolic phenotypesHüsün S Kizilkaya, Kimmie V Sørensen, Jakob S Madsen, et al.
Cell|June 24, 2025
GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesityAikaterini Motso, Benjamin Pelcman, Anastasia Kalinovich, et al.
Pageof 3